MICHAEL Flemming claims the stress of preparing for the listing of Life Healthcare on June 8 is killing him. "I don't get paid to do this," he says. It's the volatility of the JSE that is causing frayed nerves.
The planned initial public offering is the biggest in the JSE's history and could raise as much as R8bn. It is unlikely to be derailed by volatility.
The hospital group, which has a 27% share of SA's private healthcare market, was bought from Afrox and taken private in 2005 by a consortium led by Brimstone and Mvelaphanda, together with Life's senior management. This was after a hostile bid from Medi-Clinic was stymied by the competition authorities.
It was Mvelaphanda's desire to unbundle part of its shareholding that was the catalyst for the listing.
In the five years "under the radar" the 120-strong leadership team, all with "skin in the game" (their stake cost them R150m at the time), have achieved impressive growth.
The group has grown from a R4,1bn company into one, at current projections, that will achieve a market capitalisation of R15bn-R19bn on listing.
"We've closed underperforming assets and worked hard on our efficiencies," says Flemming. "Occupancies have grown by 6% to a 70% average, "which means we are sweating our assets better".
During the 2007, 2008 and 2009 financial years Life recorded adjusted Ebitda of R1,4bn, R1,7bn and R1,89bn respectively, with a compound annual growth rate over the period of 14,2%. The company has also grown margins aggressively, achieving the highest in the industry.
Its ability to sustain that growth at those margins will be under scrutiny.
Flemming believes there is room for more growth in the local market. To achieve this, Life plans to increase its bed numbers by about 10,7% (800 beds) over the next two to three years. It also plans to expand in areas in which the group has established a niche, such as its mental health, renal dialysis, acute rehabilitation and frail care lines. Three new acute care hospitals and an additional mental health facility will be built within two to three years, while another three acute care hospitals, a rehabilitation facility and two mental health facilities are acquisition targets.
SA's heavily regulated healthcare environment and proposed national health insurance are listed as risks in the prospectus. However, it is precisely this imbalance between the public and private health-care sectors that Flemming sees as an opportunity.
"There are about 4,5m people who earn above the tax threshold but do not belong to medical schemes," he says. "We [the industry] have to take some of the healthcare burden off the shoulders of government. We need to develop affordable funding models for these 4,5m people."
The advantage Life has is that it already has experience in partnerships with government, says Old Mutual Investment Group analyst Jonathan Larcombe. "They operate the country's largest public-private partnership business in Life Esidimeni, which is profitable."
One risk the prospectus does not dwell on is what happens to the 120 executives who will be able to pay down their debt plus more after the listing. Will they stick around? Flemming shakes his head. "Some people will leave. But we see that as an opportunity to advance other bright people in the organisation."
One area of differentiation, says Mark Ansley, a portfolio manager at Cadiz Asset Management, is the underlying ownership of the group's hospitals — its major assets. Life doctors have direct interest in these hospitals, together with a 7,2% shareholding in the group. "That ensures a certain loyalty, which could help drive procedures through its hospitals," he says.
Like Netcare and Medi-Clinic, Life also has an offshore expansion plan, though it will focus on emerging markets like India and Turkey, while its competitors have ventured - at huge expense -into developed markets.
"These markets are not heavily regulated," says Flemming. "Private health insurance is expanding, the private hospital sector is growing fast but is highly fragmented and there is a good supply of medical professionals and personnel."
Ansley says: "All you can value is what is in front of you - and that is the SA operation. At this point we cannot get excited about the offshore strategy. That can only happen when we know exactly what will be paid for new assets."
Life is relatively ungeared, with R2,4bn debt on its balance sheet. In comparison, Medi-Clinic and Netcare, which have ventured offshore, have about R25bn of debt on their respective balance sheets. In Medi-Clinic's case, R3bn of that debt is in SA; R4bn in the case of Netcare.
"This leaves Life with plenty of opportunity to expand further, and with little likelihood that it will return to shareholders for funding," says Larcombe.
Sasha Planting: The Financial Mail, 28 May 2010